Clinical Trials Insight: 700009424
Latest Information Update: 29 Nov 2005
Price :
$35 *
At a glance
- Drugs Interferon beta/EMZ 701 (Primary)
- Indications Multiple sclerosis
- Focus Therapeutic Use
- Sponsors Transition Therapeutics
- 29 Nov 2005 New trial record.